tiprankstipranks

Steven Lo Insider Profile

4 Followers
Steven Lo, SVP Oncology at Corcept Therapeutics, holds 146.25K shares in Zosano Pharma (Ticker: ZSAN), holds 19.56K shares in Puma Biotechnology (Ticker: PBYI), holds 585.42K shares in Corcept Therapeutics (Ticker: CORT).
tipranks
Steven Lo

Steven Lo
Corcept Therapeutics (CORT)
SVP Oncology

Ranked #36,006 out of 78,624 Corporate Insiders

Profitable Transactions

17%
1 out of 6 Profitable Transactions

Average Return

+0.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$14M
97.65%
1.66%
0.69%
A breakdown of Steven Lo's holdings

Insider Roles

Corcept Therapeutics
(CORT)
SVP Oncology
Puma Biotechnology
(PBYI)
CCO
Zosano Pharma
(ZSAN)
CEO, Director
Roles that Steven Lo holds in companies

Most Profitable Insider Trade

Stock:
Corcept Therapeutics
(CORT)
Rating:Informative Buy
Date:Nov 16, 2015 - Nov 16, 2016
Return:+97.40%
The most profitable trade made by Steven Lo

Steven Lo's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Corcept Therapeutics
Nov 16, 2015
SVP Oncology
Informative Buy
1.80M
$13.46M
Zosano Pharma
Jun 29, 2020
CEO, Director
Uninformative Buy
$94.48K
Puma Biotechnology
Jul 24, 2019
CCO
Uninformative Sell
18.59K
$229.40K
List of latest transactions for each holding click on a transaction to see Steven Lo's performance on stock

Steven Lo insider profile FAQ

What is the percentage of profitable transactions made by Steven Lo?
The percentage of profitable transactions made by Steven Lo is 17%.
    What is the average return per transaction made by Steven Lo?
    The average return per transaction made by Steven Lo is 0.90%.
      What stocks does Steven Lo hold?
      Steven Lo holds: CORT, ZSAN, PBYI stocks.
        What was Steven Lo’s latest transaction?
        Steven Lo latest transaction was an Uninformative Buy of ―.
          What was Steven Lo's most profitable transaction?
          Steven Lo’s most profitable transaction was an Informative Buy of CORT stock on November 16, 2015. The return on the trade was 97.40%.
            What is Steven Lo's role in Corcept Therapeutics?
            Steven Lo's role in Corcept Therapeutics is SVP Oncology.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.